CompletedNCT00374348
Aripiprazole for obsessive-compulsive symptoms in schizophrenia
About this title
Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)
Read the official source — NCT00374348Medication studyAges 18–65United StatesOCD
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- JamaicaSee all locations and recruitment
Study information
Study start dateMarch 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Jamaica Hospital Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00374348
- Official title
Show the full official title
"Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)".
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Jamaica
Questions about this study
Who is behind this study?
The study sponsor is Jamaica Hospital Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole.
Who was this study for?
Listed age limits: 18 years to 65 years.
